Pheochromocytoma/paraganglioma syndrome 3
MONDO:0011544An autosomal dominant tumor predisposition disorder caused by pathogenic variants in the SDHC gene, characterized by an increased risk of paraganglioma and pheochromocytoma, as well as an increased risk of renal cell carcinoma and gastrointestinal stromal tumors (GIST).
Also known as: SDHC paraganglioma, SDHC-related tumor predisposition, paraganglioma caused by mutation in SDHC, paragangliomas 3, paragangliomas type 3, pheochromocytoma/paraganglioma syndrome 3, PGL3, SDHC-related hereditary paraganglioma-pheochromocytoma syndrome (paragangliomas 3)
1495 clinical trials for this condition and its sub-types, 0 tagged with Pheochromocytoma/paraganglioma syndrome 3 itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →We haven't found any trials for this condition yet. Follow it to get notified when new trials appear.